Journal article
EPID-17. A SINGLE CENTER RESTROSPECTIVE REVIEW OF RECURRENT OR TREATMENT REFRACTORY PEDIATRIC MEDULLOBLASTOMA
Abstract
Abstract
INTRODUCTION
The outcome of pediatric refractory or relapsed brain tumours remains a concern for treating neurooncology teams with the most effective salvage therapy yet to be established. Upfront therapy for primary medulloblastoma (MB) is dependent on age, post-operative residual and evidence of metastasis at diagnosis. Children diagnosed with aggressive subtypes of MB that are refractory to upfront therapy or recur either in the …Authors
Kameda-Smith M; Manoranjan B; Ajani O; Yarascavitch B; Petrelli T; Singh S; Fleming A
Journal
Neuro-oncology, Vol. 19, No. Suppl 6, pp. vi72–vi72
Publication Date
November 2017
ISSN
1522-8517